Scarica l'app Stockscreener
32.65
2.67%
0.85
Precedente Chiudi:
$31.80
Aprire:
$32.24
Volume 24 ore:
1.64M
Relative Volume:
2.91
Capitalizzazione di mercato:
$1.62B
Reddito:
$499.95M
Utile/perdita netta:
$-36.36M
Rapporto P/E:
-42.40
EPS:
-0.77
Flusso di cassa netto:
$24.22M
1 W Prestazione:
-12.02%
1M Prestazione:
-10.30%
6M Prestazione:
-11.04%
1 anno Prestazione:
-17.53%
Intervallo 1D:
$32.00
$33.72
Intervallo di 1 settimana:
$30.47
$38.07
Portata 52W:
$28.29
$43.18
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Compare ATRC vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
32.65 | 1.58B | 499.95M | -36.36M | 24.22M | -0.77 |
|
ISRG
Intuitive Surgical Inc
|
485.84 | 169.97B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
175.89 | 50.58B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.20 | 38.58B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
44.55 | 37.11B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
252.55 | 35.80B | 5.40B | 1.49B | 1.78B | 10.12 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-11 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
Whale Trades: What are AtriCure Inc.’s recent SEC filings showing2025 Sector Review & Real-Time Volume Triggers - mfd.ru
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Atricure (ATRC) and Inspire Medical Systems (INSP) - The Globe and Mail
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
AtriCure's (ATRC) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Needham Reiterates AtriCure (ATRC) Buy Rating with $45 Price Tar - GuruFocus
Needham reiterates Buy rating on AtriCure stock amid competition By Investing.com - Investing.com India
Needham reiterates Buy rating on AtriCure stock amid competition - Investing.com
AtriCure stock maintains Market Outperform rating at Citizens despite Edwards competition By Investing.com - Investing.com South Africa
AtriCure stock maintains Market Outperform rating at Citizens despite Edwards competition - Investing.com India
(ATRC) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
JPMorgan downgrades AtriCure stock rating to Neutral on Edwards competition - Investing.com Nigeria
Sector Update: Health Care Stocks Rise Late Afternoon - marketscreener.com
Top Midday Decliners - marketscreener.com
AtriCure (ATRC) Shares Fall 15% Following JPMorgan Downgrade - GuruFocus
AtriCure (NASDAQ:ATRC) Shares Gap Down After Analyst Downgrade - MarketBeat
Is AtriCure Inc. a top pick in the sectorMarket Activity Report & Growth Focused Investment Plans - mfd.ru
AtriCure (NASDAQ:ATRC) Rating Lowered to Neutral at JPMorgan Chase & Co. - MarketBeat
JPMorgan Downgrades AtriCure to Neutral From Overweight, Adjusts PT to $36 From $48 - marketscreener.com
Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
AtriCure (ATRC) Projected to Post Earnings on Tuesday - MarketBeat
Profit Review: Is AtriCure Inc a potential multi baggerJuly 2025 News Drivers & Consistent Return Strategy Ideas - baoquankhu1.vn
First Week of March 20th Options Trading For AtriCure (ATRC) - Nasdaq
AtriCure (NASDAQ:ATRC) Stock Price Passes Above 200-Day Moving AverageWhat's Next? - MarketBeat
Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Wave Life Sciences (WVE) and Arcellx Inc (ACLX) - The Globe and Mail
AtriCure, Inc. (ATRC) Stock Analysis: A Compelling 43% Upside Potential For Investors - DirectorsTalk Interviews
AtriCure stock maintains Overweight rating at Piper Sandler on BoxX-NoAF potential - Investing.com India
AtriCure stock maintains Overweight rating at Piper Sandler on BoxX-NoAF potential By Investing.com - Investing.com South Africa
(ATRC) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Local public company secures incentive for $45M project, likely to create hundreds of jobs - WKRC
Income Plays: Is AtriCure Inc a cyclical or defensive stock2025 Technical Patterns & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Weekly Recap: Will ARS Pharmaceuticals Inc announce a stock splitJuly 2025 Outlook & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Red-hot medical device firm gets big JobsOhio grant for $45M expansion - The Business Journals
Reasons to Retain Avanos Medical Stock in Your Portfolio Now - sharewise.com
When Will AtriCure, Inc. (NASDAQ:ATRC) Turn A Profit? - 富途牛牛
Market Wrap: Does AtriCure Inc have declining or rising EPSJuly 2025 Technicals & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Riverwater Partners LLC Buys 26,657 Shares of AtriCure, Inc. $ATRC - MarketBeat
AtriCure to Announce Fourth Quarter and Full Year 2025 Financial Results - Chartmill
The Zacks Analyst Blog Highlights AtriCure, REV Group, Oceaneering International and Analog Devices - Yahoo Finance
Market Pulse: Is AtriCure Inc stock trending bullish2025 Investor Takeaways & Real-Time Volume Spike Alerts - baoquankhu1.vn
SG Americas Securities LLC Has $824,000 Position in AtriCure, Inc. $ATRC - MarketBeat
(ATRC) Risk Channels and Responsive Allocation - Stock Traders Daily
AtriCure, Inc. (ATRC) Stock Analysis: A Promising 35% Upside Potential Amid Strong Buy Ratings - DirectorsTalk Interviews
AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
AtriCure (ATRC) Is Down 5.8% After Issuing 2026 Profitability Guidance And Expanding Credit Facility - Yahoo Finance
What are AtriCure Incs recent SEC filings showingMarket Growth Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Intuitive Surgical Stock Dips on Q4 Preliminary Revenue Results - Prime Publishers, Inc.
AI Diagnostics: The End of the High-Cost Imaging Era - GlobeNewswire
AtriCure Stock (+11%): Profitability Inflection Ignites Re-Rate - Trefis
AtriCure (NASDAQ:ATRC) Trading 6.7% HigherHere's Why - MarketBeat
AtriCure Inc (ATRC) Shares Up 8.49% on Jan 15 - GuruFocus
AtriCure CEO Touts $10B AFib and Pain Market, Raises EBITDA Outlook at JPMorgan Conference - MarketBeat
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Atricure Inc Azioni (ATRC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| WEHRWEIN SVEN | Director |
Nov 25 '25 |
Option Exercise |
19.95 |
4,967 |
99,092 |
39,341 |
| WEHRWEIN SVEN | Director |
Nov 25 '25 |
Sale |
38.00 |
4,967 |
188,746 |
34,374 |
| WEHRWEIN SVEN | Director |
Nov 24 '25 |
Sale |
37.32 |
5,033 |
187,832 |
34,374 |
| Noznesky Justin J | Chief Mktg & Strategy Officer |
Nov 26 '25 |
Sale |
37.29 |
5,166 |
192,640 |
78,798 |
0.53%
1.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):